World Updates

World Updates

Sabarimala Gold Case: SIT Probe Extended

by
Ubuntu Tribe Brings Tokenized Gold to Digital Asset Era

The Kerala High Court was told on Monday by the Special Investigation Team (SIT) looking into the Sabarimala gold heist case that it is also looking into transactions involving the replating of temple artifacts that took place in 2025. Additional Time Granted to SIT In an interim judgment, a division bench consisting of Justices Raja … Read more

Cosmos Health Stock Rises on Libytec Manufacturing Deal

by
Grover Jewells' shares surpass gray market predictions by listing at a 9% premium to the SME IPO price. On February 11, Grover Jewells' shares made a modest debut on the stock market, going up to Rs 96 per on the NSE Emerge platform. This is a premium of almost 9% above the Rs 88 IPO price per share. With a market valuation of Rs 139.27 crore, the company made its debut on the stock exchanges. Grey market estimates versus listing premium: The listing premium has greatly exceeded grey market expectations, even with the market's lackluster beginning. The company's unlisted shares were trading flat at the IPO price of Rs 88 with no grey market premium (GMP) prior to listing. When the IPO was up for public bidding from February 4 to February 6, the site's quoted GMP was close to 3 percent. The company's unlisted shares were trading at 0 GMP over the IPO price, according to IPO Watch as well. Grover Jewells IPO: Grover Jewells, a gold jewelry manufacturer situated in Delhi, went public in order to generate Rs 33.83 crore by issuing 38.44 lakh shares at a price range of Rs 83–88 each. With a minimum investment of Rs 1.41 lakh, investors could bid for 1,600 shares, and then in multiples. The IPO received over 19 subscriptions between February 4 and February 6, indicating that investors were quite interested in it throughout its three days of public bidding. With approximately 38 bookings of their allotted allocation, non-institutional investors (NII) shown the highest level of interest in the IPO. Qualified institutional buyers (QIB) and retail sections were reserved 11 times and 16 times, respectively. Working capital will be the primary use of the IPO proceeds, with the remaining sum going toward general business needs.

Cosmos Health Stock Surges on PathMuscle Manufacturing Deal Following the announcement of a manufacturing deal for PathMuscle, a pharmaceutical product that combines a muscle relaxant and pain reliever, Cosmos Health Inc. (NASDAQ:COSM) shares increased 3.7% on Monday. Details of the PathMuscle Manufacturing Agreement Libytec Pharmaceutical S.A., which has exclusive distribution rights in Greece, will get … Read more

US Tariff Threat May Hit Indian Exports, Say Experts

by
Ford CEO Discusses US-China Auto JV Framework

Experts warned that any action by the US to raise import taxes or tariffs on Indian products might have a negative effect on the nation’s exports to Washington. US Tariff Threat Raises Export Concerns But, they said, it may also force exporters to de-risk their international markets and diversify more quickly. Speaking to reporters on … Read more